Biphenotypic sinonasal sarcoma with PAX3/FOXO1 fusion.

Pol J Pathol

Department of Pathology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.

Published: March 2024

Biphenotypic sinonasal sarcoma (BSNS), previously known as low-grade sinonasal sarcoma, is a rare tumour of the sinonasal tract, first described in 2012. It involves both myogenic and neural differentiation and is characterized by PAX3 rearrangement. MAML3 is the most frequent fusion partner of PAX3; however, its partner remains unidentified in a subset of cases. These tumours have significant local recurrence rates but lack metastatic potential. Here, we report a case of BSNS with PAX3/FOXO1 fusion and discuss its clinicopathological features and differential diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.5114/pjp.2023.134321DOI Listing

Publication Analysis

Top Keywords

sinonasal sarcoma
12
biphenotypic sinonasal
8
pax3/foxo1 fusion
8
sarcoma pax3/foxo1
4
fusion biphenotypic
4
sarcoma bsns
4
bsns low-grade
4
low-grade sinonasal
4
sarcoma a rare
4
a rare tumour
4

Similar Publications

Uncommon Nasal Mass Presentation: A Radiological Case Series.

J Pers Med

December 2024

Radiological Sciences Section, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, AOUP "Paolo Giaccone", Via del Vespro 129, 90127 Palermo, Italy.

Nasal and paranasal sinus masses can arise from a wide range of conditions, both benign and malignant, as well as congenital or acquired. Diagnosing these masses is often challenging, requiring a combination of nasal endoscopy, imaging studies, and histopathological analysis. Initial imaging frequently involves computed tomography or cone beam computed tomography (CBCT) to evaluate the bony anatomy of the nasal cavity and surrounding sinuses, while magnetic resonance imaging (MRI) is typically used for detailed assessment of soft tissues and to aid in differential diagnosis when the findings are inconclusive.

View Article and Find Full Text PDF

Biphenotypic sinonasal sarcoma in a toddler: a case report and literature review.

Eur Arch Otorhinolaryngol

December 2024

Department of Otolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.

Introduction: Biphenotypic sinonasal sarcoma (BSNS) is an extremely rare malignant tumor characterized by neural and myogenic differentiation. No documented cases of BSNS have been reported in toddlers.

Case Report: A 1-year-11-month-old girl presented with significant unilateral nasal bleeding.

View Article and Find Full Text PDF

Ewing Sarcoma of the Sinonasal Tract: A Scoping Review.

Laryngoscope

November 2024

Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine, Bronx, New York, U.S.A.

Objective: Ewing sarcoma (ES) is a rare aggressive malignancy that can present in the sinonasal region. The objective of this study is to investigate the demographics, presentation, management, and outcomes of patients with sinonasal ES.

Data Sources: PubMed, Web of Science, SCOPUS, CINAHL, and Cochrane Library.

View Article and Find Full Text PDF

Biphenotypic Sinonasal Sarcoma: Literature Review of a Peculiar Pathological Entity-The Neurosurgical Point of View.

Cancers (Basel)

November 2024

Department of Neurosciences and Reproductive and Odontostomatological Sciences, Division of Neurosurgery, University of Naples "Federico II", 80131 Naples, Italy.

Background: Biphenotypic sinonasal sarcoma (BSNS) is a low-grade tumor of the sinonasal tract with frequent extension to the orbit and skull base. Due to its rare incidence and recent histopathological and molecular characterization, little data are available in regard to its natural history, treatment and surveillance protocol.

Methods: A comprehensive literature review in Embase online electronic databases on BSNS was made.

View Article and Find Full Text PDF

TFE3 rearrangements characterize histogenetically, topographically, and biologically diverse neoplasms. Besides being a universal defining feature in alveolar soft part sarcoma (ASPS) and clear cell stromal tumor of the lung, TFE3 fusions have been reported in subsets of renal cell carcinoma, perivascular epithelioid cell tumor (PEComa), epithelioid hemangioendothelioma and ossifying fibromyxoid tumors. TFE3-related neoplasms are rare in the head and neck and may pose diagnostic challenges.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!